RxDoctor Payments Data

Sherri Walling, NP

Nurse Practitioner · Evansville, INNPI 1497799100

Payments from drug & device makers

$440in general payments, 2019–2025

Across 33 payments — averaging $13.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$201
  • Axsome Therapeutics, Inc.$50
  • Sunovion Pharmaceuticals Inc.$47
  • Otsuka America Pharmaceutical, Inc.$41
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$40
  • Alkermes, Inc.$25
  • plus $37 from 2 others

What the payments were for

  • Food & beverage$440100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$440 in reported general payments places this provider in the 60th percentile of 2,724 nurse practitioner providers in Indiana.

See all nurse practitioner providers in Indiana

Medicare billing

Part B allowed, 2024
$26,669
Medicare patients
114
Services billed
335

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl81$125,984
RexultiBrexpiprazole18$35,218
TrintellixVortioxetine Hydrobromide36$21,735
AuvelityDextromethorphan Hbr/Bupropion14$14,719
VyvanseLisdexamfetamine Dimesylate36$13,981
Divalproex Sodium ErDivalproex Sodium58$10,740
Aripiprazole129$10,196
Lurasidone Hcl61$8,289
BelsomraSuvorexant18$7,821
SaphrisAsenapine Maleate13$7,500
Lisdexamfetamine Dimesylate31$5,393
Ziprasidone Hcl59$5,344
Paliperidone ErPaliperidone18$5,175
Clozapine74$5,092
Buspirone Hcl285$5,033

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar, Saphris$201$133,48494 claims
Otsuka America Pharmaceutical, Inc.Rexulti$41$35,21818 claims
Axsome Therapeutics, Inc.Auvelity$50$14,71914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 2,724 nurse practitioner providers in Indiana.

Other nurse practitioner in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →